Neos Therapeutics's revenue for the
three
months ended in Sep. 2020 was $12.54 Mil.
Its revenue for the trailing twelve months (TTM) ended in Sep. 2020 was $56.99 Mil.
Neos Therapeutics's Revenue per Share for the
three
months ended in Sep. 2020 was $0.25.
Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was $1.15.
Warning Sign:
Neos Therapeutics Inc revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Neos Therapeutics was -14.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 25.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 78.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 7 years, Neos Therapeutics's highest 3-Year average Revenue per Share Growth Rate was 180.40% per year. The lowest was 25.40% per year. And the median was 83.70% per year.
Neos Therapeutics Revenue Historical Data
The historical data trend for Neos Therapeutics's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Neos Therapeutics's Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Neos Therapeutics's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neos Therapeutics's Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Neos Therapeutics's Revenue distribution charts can be found below:
* The bar in red indicates where Neos Therapeutics's Revenue falls into.
Neos Therapeutics Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Sep. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $56.99 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neos Therapeutics (NAS:NEOS) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Neos Therapeutics Revenue Related Terms
Thank you for viewing the detailed overview of Neos Therapeutics's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Neos Therapeutics (Neos Therapeutics) Business Description
Neos Therapeutics Inc is a pharmaceutical company, engaged in the development, manufacture, and commercialization of products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technologies. The product portfolio of the company includes Methylphenidate XR-ODT and Amphetamine XR oral suspension commonly prescribed medicine for the treatment of ADHD. In addition, it also manufactures and markets generic Tussionex, a hydrocodone polistirex and chlorpheniramine polistirex XR liquid suspension product indicated for the relief of cough. Geographically, it operates through the United States and derives revenue through the sale of products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NEOS has been successfully added to your 